Results 51 to 60 of about 2,316,942 (186)
Study evaluated the effectiveness and safety of topical tranexamic acid in breast surgery. Topical TXA reduced postoperative haematoma risk by 75% and significantly decreased postoperative drain output compared with controls, while seroma rates were unchanged.
Sina Sobhanmanesh +2 more
wiley +1 more source
Cancer pain: current practice and emerging targets
Cancer pain (CP) arises from a complex interplay between the tumour and its microenvironment. Many patients experience a mixed pain phenotype that encompasses nociceptive, neuropathic and neuroinflammatory mechanisms, and vary across tumour type and disease stage. Despite decades of intensive research, the mainstay of cancer pain treatment is still non‐
Yi Ye +5 more
wiley +1 more source
Management and Outcomes of Male Breast Cancer in Zaria, Nigeria
Male breast cancer is an uncommon disease accounting for only 1% of all breast cancers. We present the evaluation, treatment and outcome of male patients seen with breast cancer in our institution.
Adamu Ahmed +3 more
doaj +1 more source
Differentiating Inflammatory Breast Cancer From Lactational Mastitis: A Diagnostic Challenge
Abstract Inflammatory breast cancer (IBC) is a rare but aggressive form of cancer; hence, early diagnosis is essential. Although predominantly occurring in older women, it can occur during pregnancy and lactation, making the diagnosis especially challenging.
Irena Zakarija‐Grković
wiley +1 more source
Cutaneous Erythema at Scar Site of Modified Radical Mastectomy: An Unexpected Manifestation of Recurrent Carcinoma [PDF]
A 44-year-old woman presented with marked erythema over right mastectomy scar, while on Herceptin therapy. She had neoadjuvant chemotherapy, modified radical mastectomy, and radiotherapy less than one year earlier for the treatment of invasive ductal ...
Awrad Mohammed-Reda Nasralla +3 more
core +1 more source
Breast Cancer Outcomes From Ductal Carcinoma In Situ: A Population‐Based Cohort Study
Women with ductal carcinoma in situ have an elevated risk of subsequent invasive breast cancer, but how this risk evolves over time is unclear. In this population‐based study of ethnically diverse women diagnosed between 2000 and 2022 in New Zealand, the risk of invasive ipsilateral breast cancer persisted beyond 5 years.
Qian Chen +5 more
wiley +1 more source
Solitary adrenal metastasis from invasive ductal breast cancer: an uncommon finding
Background Invasive ductal carcinoma (IDC) of the breast usually metastasizes to the lungs, liver, bones and brain. Solitary adrenal metastasis is extremely rare. Due to the rarity of this condition, the optimal treatment is unclear.
Sun Ke +4 more
doaj +1 more source
ABSTRACT Locoregional pathological complete response with concurrent radiologic metabolic remission following palliative gemcitabine–carboplatin chemotherapy in young, low‐grade metastatic triple‐negative breast cancer patient suggests potential chemosensitivity in select advanced cases, warranting further clinical investigation.
Shristi Gupta +5 more
wiley +1 more source
To determine the frequency of post-mastectomy pain syndrome (PMPS) among women undergoing modified radical mastectomy for breast cancer. Study Design: Prospective observational study. Place and Duration of Study: The study was conducted in the Department
Aisha Shaikh +5 more
core +1 more source
ABSTRACT Background Breast cancer survival has improved substantially, yet many women continue to experience late effects that may require physiotherapy. Shoulder impairment, lymphedema, and fatigue are among the most common physiotherapy‐relevant late effects following primary breast cancer treatment.
Kim Michéle Feder +4 more
wiley +1 more source

